SedMed, a Connecticut-based medical device company has secured $4 million in funding from 108 BioCapital. The investment will support the company’s next stage of commercial growth and expand access to its non-electric toilet lift for people with mobility limitations.
SedMed develops mobility products designed to help older adults and people with limited mobility sit down and stand up more safely and independently. Its solutions also aim to reduce the physical strain placed on caregivers.
“SedMed is addressing an important and often overlooked challenge for older adults, individuals with limited mobility and their caregivers,” said Sasha Bakhru, Managing Partner of 108 BioCapital. “The company has developed an intuitive, non-electric solution with the potential to improve safety, preserve independence and reduce caregiver burden across home and healthcare settings. We have been impressed by Jeremy and the SedMed team’s thoughtful approach to product development and commercialization, and we are pleased to lead this investment and support the company’s next phase of growth.”
The company’s flagship product, the SedMed Toilet Lift, attaches to most standard toilets and provides adjustable assistance when sitting and standing. The device does not require electricity, batteries or bathroom remodeling, making it suitable for use in homes, senior living communities and healthcare settings.
“SedMed’s adoption across more than 40 hospital systems demonstrates strong demand for its solution and validates the important role it can play in addressing a significant challenge for healthcare providers,” said Shahryar Oveissi, General Partner of 108 BioCapital. “That momentum also sets the stage for SedMed to become a trusted solution for older adults living at home, where physical limitations, cognitive decline and environmental barriers can increase the risk of accidents and place added strain on caregivers.”
“SedMed’s practical, non-electric design gives the product meaningful potential beyond the United States,” said Shom Jagtiani, General Partner of 108 BioCapital. “We see particular opportunity in India and other international markets, where an easy-to-deploy solution could help improve bathroom safety and independence for older adults across home and healthcare settings.”
“This investment represents an important milestone for SedMed as we work to make safer bathroom mobility accessible to more people,” said Jeremy Bronen, CEO of SedMed. “108 BioCapital brings healthcare expertise and a shared commitment to supporting technologies that can meaningfully improve the lives of patients and caregivers. This funding will allow us to expand our commercial reach, strengthen our distribution network and build additional evidence demonstrating the value SedMed can provide to healthcare organizations.”
SedMed plans to use the new investment to accelerate its commercial expansion and grow its distribution and channel partnerships. The company will also invest in its intellectual property portfolio and conduct additional studies in hospital settings.
Based in Milford, Connecticut, SedMed focuses on developing non-electric mobility solutions that support bathroom safety, independence and dignity for older adults and people with limited mobility.
The funding from 108 BioCapital is expected to help SedMed expand the availability of its products as demand grows for mobility solutions that can improve independence while reducing caregiver burden.
